Report cover image

Global Paroxetine Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 192 Pages
SKU # APRC20553511

Description

Summary

According to APO Research, The global Paroxetine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Paroxetine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Paroxetine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Paroxetine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Paroxetine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Paroxetine include Teva, Sun Pharmaceutical, Mylan, Aurobindo, Sebela Pharmaceuticals, Neurocon Inc, Lupin, Lifegenix and Lannett Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Paroxetine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Paroxetine, also provides the sales of main regions and countries. Of the upcoming market potential for Paroxetine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Paroxetine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Paroxetine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Paroxetine sales, projected growth trends, production technology, application and end-user industry.

Paroxetine Segment by Company

Teva
Sun Pharmaceutical
Mylan
Aurobindo
Sebela Pharmaceuticals
Neurocon Inc
Lupin
Lifegenix
Lannett Company
Jubilant Pharma
Apotex
Paroxetine Segment by Type

Paroxetine Hydrochloride Drug
Paroxetine Mesylate Drug
Paroxetine Segment by Application

Depression
Social anxiety disorder
Panic disorder
Others
Paroxetine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paroxetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Paroxetine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paroxetine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Paroxetine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Paroxetine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Paroxetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Paroxetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

192 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Paroxetine Market Size, 2020 VS 2024 VS 2031
1.3 Global Paroxetine Market Size Estimates and Forecasts (2020-2031)
1.4 Global Paroxetine Sales Estimates and Forecasts (2020-2031)
1.5 Global Paroxetine Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Paroxetine Market Dynamics
2.1 Paroxetine Industry Trends
2.2 Paroxetine Industry Drivers
2.3 Paroxetine Industry Opportunities and Challenges
2.4 Paroxetine Industry Restraints
3 Paroxetine Market by Manufacturers
3.1 Global Paroxetine Revenue by Manufacturers (2020-2025)
3.2 Global Paroxetine Sales by Manufacturers (2020-2025)
3.3 Global Paroxetine Average Sales Price by Manufacturers (2020-2025)
3.4 Global Paroxetine Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Paroxetine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Paroxetine Manufacturers, Product Type & Application
3.7 Global Paroxetine Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Paroxetine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Paroxetine Players Market Share by Revenue in 2024
3.8.3 2024 Paroxetine Tier 1, Tier 2, and Tier 3
4 Paroxetine Market by Type
4.1 Paroxetine Type Introduction
4.1.1 Paroxetine Hydrochloride Drug
4.1.2 Paroxetine Mesylate Drug
4.2 Global Paroxetine Sales by Type
4.2.1 Global Paroxetine Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Paroxetine Sales by Type (2020-2031)
4.2.3 Global Paroxetine Sales Market Share by Type (2020-2031)
4.3 Global Paroxetine Revenue by Type
4.3.1 Global Paroxetine Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Paroxetine Revenue by Type (2020-2031)
4.3.3 Global Paroxetine Revenue Market Share by Type (2020-2031)
5 Paroxetine Market by Application
5.1 Paroxetine Application Introduction
5.1.1 Depression
5.1.2 Social anxiety disorder
5.1.3 Panic disorder
5.1.4 Others
5.2 Global Paroxetine Sales by Application
5.2.1 Global Paroxetine Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Paroxetine Sales by Application (2020-2031)
5.2.3 Global Paroxetine Sales Market Share by Application (2020-2031)
5.3 Global Paroxetine Revenue by Application
5.3.1 Global Paroxetine Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Paroxetine Revenue by Application (2020-2031)
5.3.3 Global Paroxetine Revenue Market Share by Application (2020-2031)
6 Global Paroxetine Sales by Region
6.1 Global Paroxetine Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Paroxetine Sales by Region (2020-2031)
6.2.1 Global Paroxetine Sales by Region (2020-2025)
6.2.2 Global Paroxetine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Paroxetine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Paroxetine Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Paroxetine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Paroxetine Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Paroxetine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Paroxetine Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Paroxetine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Paroxetine Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Paroxetine Revenue by Region
7.1 Global Paroxetine Revenue by Region
7.1.1 Global Paroxetine Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Paroxetine Revenue by Region (2020-2025)
7.1.3 Global Paroxetine Revenue by Region (2026-2031)
7.1.4 Global Paroxetine Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Paroxetine Revenue (2020-2031)
7.2.2 North America Paroxetine Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Paroxetine Revenue (2020-2031)
7.3.2 Europe Paroxetine Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Paroxetine Revenue (2020-2031)
7.4.2 Asia-Pacific Paroxetine Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Paroxetine Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Paroxetine Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Teva
8.1.1 Teva Comapny Information
8.1.2 Teva Business Overview
8.1.3 Teva Paroxetine Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Teva Paroxetine Product Portfolio
8.1.5 Teva Recent Developments
8.2 Sun Pharmaceutical
8.2.1 Sun Pharmaceutical Comapny Information
8.2.2 Sun Pharmaceutical Business Overview
8.2.3 Sun Pharmaceutical Paroxetine Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Sun Pharmaceutical Paroxetine Product Portfolio
8.2.5 Sun Pharmaceutical Recent Developments
8.3 Mylan
8.3.1 Mylan Comapny Information
8.3.2 Mylan Business Overview
8.3.3 Mylan Paroxetine Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Mylan Paroxetine Product Portfolio
8.3.5 Mylan Recent Developments
8.4 Aurobindo
8.4.1 Aurobindo Comapny Information
8.4.2 Aurobindo Business Overview
8.4.3 Aurobindo Paroxetine Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Aurobindo Paroxetine Product Portfolio
8.4.5 Aurobindo Recent Developments
8.5 Sebela Pharmaceuticals
8.5.1 Sebela Pharmaceuticals Comapny Information
8.5.2 Sebela Pharmaceuticals Business Overview
8.5.3 Sebela Pharmaceuticals Paroxetine Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Sebela Pharmaceuticals Paroxetine Product Portfolio
8.5.5 Sebela Pharmaceuticals Recent Developments
8.6 Neurocon Inc
8.6.1 Neurocon Inc Comapny Information
8.6.2 Neurocon Inc Business Overview
8.6.3 Neurocon Inc Paroxetine Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Neurocon Inc Paroxetine Product Portfolio
8.6.5 Neurocon Inc Recent Developments
8.7 Lupin
8.7.1 Lupin Comapny Information
8.7.2 Lupin Business Overview
8.7.3 Lupin Paroxetine Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Lupin Paroxetine Product Portfolio
8.7.5 Lupin Recent Developments
8.8 Lifegenix
8.8.1 Lifegenix Comapny Information
8.8.2 Lifegenix Business Overview
8.8.3 Lifegenix Paroxetine Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Lifegenix Paroxetine Product Portfolio
8.8.5 Lifegenix Recent Developments
8.9 Lannett Company
8.9.1 Lannett Company Comapny Information
8.9.2 Lannett Company Business Overview
8.9.3 Lannett Company Paroxetine Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Lannett Company Paroxetine Product Portfolio
8.9.5 Lannett Company Recent Developments
8.10 Jubilant Pharma
8.10.1 Jubilant Pharma Comapny Information
8.10.2 Jubilant Pharma Business Overview
8.10.3 Jubilant Pharma Paroxetine Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Jubilant Pharma Paroxetine Product Portfolio
8.10.5 Jubilant Pharma Recent Developments
8.11 Apotex
8.11.1 Apotex Comapny Information
8.11.2 Apotex Business Overview
8.11.3 Apotex Paroxetine Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Apotex Paroxetine Product Portfolio
8.11.5 Apotex Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Paroxetine Value Chain Analysis
9.1.1 Paroxetine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Paroxetine Production Mode & Process
9.2 Paroxetine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Paroxetine Distributors
9.2.3 Paroxetine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.